Robert Weinstein
Concepts (313)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glucocorticoids | 13 | 2017 | 235 | 3.320 |
Why?
| Bone and Bones | 21 | 2024 | 494 | 2.190 |
Why?
| Osteocytes | 15 | 2015 | 226 | 2.060 |
Why?
| Osteoblasts | 29 | 2024 | 475 | 1.900 |
Why?
| Osteoporosis | 10 | 2018 | 162 | 1.730 |
Why?
| Apoptosis | 21 | 2017 | 1119 | 1.610 |
Why?
| Osteonecrosis | 4 | 2017 | 35 | 1.560 |
Why?
| Osteoclasts | 20 | 2017 | 428 | 1.530 |
Why?
| Diphosphonates | 8 | 2013 | 92 | 1.480 |
Why?
| Bone Density | 25 | 2024 | 399 | 1.430 |
Why?
| Bone Density Conservation Agents | 6 | 2013 | 75 | 1.140 |
Why?
| Bone Remodeling | 11 | 2017 | 155 | 0.990 |
Why?
| Alendronate | 5 | 2011 | 24 | 0.960 |
Why?
| Osteogenesis | 11 | 2018 | 366 | 0.810 |
Why?
| Prednisolone | 5 | 2011 | 56 | 0.800 |
Why?
| Aging | 10 | 2017 | 701 | 0.670 |
Why?
| Hypophosphatemia | 1 | 2019 | 5 | 0.660 |
Why?
| Parathyroid Hormone | 7 | 2010 | 149 | 0.660 |
Why?
| Mice | 38 | 2024 | 5949 | 0.610 |
Why?
| Animals | 45 | 2024 | 13505 | 0.570 |
Why?
| Femur Head Necrosis | 1 | 2017 | 17 | 0.570 |
Why?
| Femur Head | 1 | 2017 | 25 | 0.560 |
Why?
| Estrogen Receptor alpha | 5 | 2015 | 85 | 0.470 |
Why?
| Bone Resorption | 10 | 2014 | 302 | 0.470 |
Why?
| RANK Ligand | 9 | 2014 | 187 | 0.430 |
Why?
| Mice, Inbred C57BL | 18 | 2018 | 1884 | 0.430 |
Why?
| Osteoprotegerin | 2 | 2011 | 53 | 0.390 |
Why?
| Oxidative Stress | 8 | 2013 | 807 | 0.350 |
Why?
| Femur | 8 | 2016 | 135 | 0.340 |
Why?
| Imidazoles | 1 | 2010 | 124 | 0.320 |
Why?
| Neovascularization, Physiologic | 1 | 2009 | 72 | 0.320 |
Why?
| Water | 1 | 2009 | 82 | 0.320 |
Why?
| Wnt Signaling Pathway | 4 | 2016 | 94 | 0.310 |
Why?
| Spinal Fractures | 1 | 2009 | 38 | 0.310 |
Why?
| Forkhead Transcription Factors | 4 | 2014 | 116 | 0.310 |
Why?
| Mice, Transgenic | 11 | 2024 | 552 | 0.290 |
Why?
| Gene Deletion | 6 | 2015 | 272 | 0.270 |
Why?
| Orchiectomy | 3 | 2015 | 38 | 0.260 |
Why?
| Female | 32 | 2024 | 28171 | 0.260 |
Why?
| Maxillary Diseases | 1 | 2006 | 2 | 0.250 |
Why?
| Calcium | 6 | 2014 | 376 | 0.250 |
Why?
| Jaw | 1 | 2006 | 4 | 0.250 |
Why?
| Cell Differentiation | 6 | 2013 | 665 | 0.250 |
Why?
| Cells, Cultured | 10 | 2018 | 1567 | 0.230 |
Why?
| Male | 21 | 2024 | 26761 | 0.230 |
Why?
| Membrane Proteins | 2 | 2024 | 335 | 0.230 |
Why?
| Blindness | 1 | 2024 | 32 | 0.230 |
Why?
| Humans | 26 | 2024 | 52483 | 0.230 |
Why?
| GTP Phosphohydrolases | 1 | 2024 | 30 | 0.220 |
Why?
| Signal Transduction | 7 | 2015 | 1671 | 0.220 |
Why?
| Dexamethasone | 4 | 2011 | 438 | 0.210 |
Why?
| Spine | 6 | 2016 | 89 | 0.210 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2003 | 23 | 0.210 |
Why?
| Estrogen Replacement Therapy | 1 | 2003 | 28 | 0.210 |
Why?
| Menopause | 1 | 2003 | 38 | 0.210 |
Why?
| Porosity | 3 | 2017 | 31 | 0.200 |
Why?
| Double-Blind Method | 3 | 2010 | 713 | 0.190 |
Why?
| Femoral Fractures | 2 | 2013 | 41 | 0.190 |
Why?
| Cell Line | 3 | 2011 | 1030 | 0.190 |
Why?
| Wnt Proteins | 4 | 2016 | 100 | 0.190 |
Why?
| Estrogens | 4 | 2012 | 223 | 0.180 |
Why?
| Reactive Oxygen Species | 5 | 2014 | 421 | 0.180 |
Why?
| Periosteum | 2 | 2012 | 26 | 0.170 |
Why?
| Osteogenesis Imperfecta | 1 | 2020 | 37 | 0.170 |
Why?
| Middle Aged | 8 | 2020 | 13028 | 0.160 |
Why?
| Enhancer Elements, Genetic | 2 | 2011 | 58 | 0.160 |
Why?
| Calcitriol | 1 | 2019 | 39 | 0.160 |
Why?
| Phosphates | 1 | 2019 | 49 | 0.160 |
Why?
| Fibroblast Growth Factors | 1 | 2019 | 46 | 0.160 |
Why?
| Hyperparathyroidism | 2 | 2011 | 31 | 0.150 |
Why?
| Iron | 1 | 2019 | 127 | 0.150 |
Why?
| Stem Cells | 4 | 2013 | 177 | 0.150 |
Why?
| Single-Chain Antibodies | 1 | 2018 | 21 | 0.150 |
Why?
| Lumbar Vertebrae | 2 | 2013 | 104 | 0.150 |
Why?
| Epitopes | 1 | 2018 | 65 | 0.140 |
Why?
| Immunoglobulin M | 1 | 2018 | 60 | 0.140 |
Why?
| Blotting, Western | 4 | 2016 | 590 | 0.140 |
Why?
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 2 | 2009 | 12 | 0.140 |
Why?
| Androgens | 2 | 2015 | 70 | 0.130 |
Why?
| Mice, Knockout | 6 | 2018 | 879 | 0.130 |
Why?
| Adult | 5 | 2020 | 14161 | 0.130 |
Why?
| Autophagy | 2 | 2015 | 193 | 0.130 |
Why?
| Osteopetrosis | 1 | 2015 | 3 | 0.130 |
Why?
| rac GTP-Binding Proteins | 1 | 2015 | 5 | 0.130 |
Why?
| rac1 GTP-Binding Protein | 1 | 2015 | 12 | 0.120 |
Why?
| Neuropeptides | 1 | 2015 | 37 | 0.120 |
Why?
| Apolipoproteins E | 1 | 2016 | 55 | 0.120 |
Why?
| Gene Expression Regulation | 3 | 2011 | 990 | 0.120 |
Why?
| Bone Diseases, Metabolic | 1 | 2016 | 78 | 0.120 |
Why?
| Receptors, Androgen | 1 | 2015 | 46 | 0.120 |
Why?
| X-Ray Microtomography | 4 | 2016 | 79 | 0.120 |
Why?
| Aorta | 1 | 2016 | 165 | 0.120 |
Why?
| Diaphyses | 2 | 2013 | 4 | 0.120 |
Why?
| Estradiol | 3 | 2013 | 214 | 0.110 |
Why?
| Calcium, Dietary | 1 | 2014 | 14 | 0.110 |
Why?
| Biopsy | 2 | 2009 | 605 | 0.110 |
Why?
| Catalase | 1 | 2014 | 73 | 0.110 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2016 | 399 | 0.110 |
Why?
| Antibodies, Monoclonal, Humanized | 2 | 2013 | 236 | 0.110 |
Why?
| bcl-2-Associated X Protein | 1 | 2014 | 58 | 0.110 |
Why?
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2014 | 21 | 0.110 |
Why?
| Hydrogen Peroxide | 1 | 2014 | 120 | 0.110 |
Why?
| Organ Size | 3 | 2015 | 228 | 0.110 |
Why?
| Atherosclerosis | 1 | 2016 | 219 | 0.100 |
Why?
| Tooth Socket | 1 | 2013 | 1 | 0.100 |
Why?
| Dental Implants | 1 | 2013 | 14 | 0.100 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 179 | 0.100 |
Why?
| Cell Count | 4 | 2016 | 149 | 0.100 |
Why?
| Cell Proliferation | 5 | 2018 | 1023 | 0.100 |
Why?
| Weight-Bearing | 1 | 2012 | 45 | 0.100 |
Why?
| Osteoporotic Fractures | 1 | 2012 | 11 | 0.100 |
Why?
| Teriparatide | 1 | 2012 | 10 | 0.100 |
Why?
| Risk Factors | 3 | 2013 | 3889 | 0.100 |
Why?
| Cell Nucleus | 1 | 2013 | 187 | 0.100 |
Why?
| Bone Demineralization, Pathologic | 1 | 2011 | 5 | 0.100 |
Why?
| Drug Monitoring | 1 | 2012 | 83 | 0.090 |
Why?
| Bone Matrix | 1 | 2011 | 16 | 0.090 |
Why?
| Lactation | 1 | 2011 | 60 | 0.090 |
Why?
| Transcription Factors | 4 | 2013 | 566 | 0.090 |
Why?
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 20 | 0.090 |
Why?
| Prednisone | 1 | 2011 | 102 | 0.090 |
Why?
| Radiography | 4 | 2013 | 470 | 0.090 |
Why?
| Vitamin D | 1 | 2011 | 90 | 0.090 |
Why?
| Minerals | 1 | 2010 | 26 | 0.090 |
Why?
| Advisory Committees | 1 | 2010 | 71 | 0.090 |
Why?
| Anti-Inflammatory Agents | 1 | 2011 | 166 | 0.090 |
Why?
| Bone Diseases | 1 | 2011 | 96 | 0.080 |
Why?
| Fractures, Bone | 1 | 2011 | 107 | 0.080 |
Why?
| Research | 1 | 2010 | 107 | 0.080 |
Why?
| Interleukin-6 | 2 | 2016 | 278 | 0.080 |
Why?
| Drug Administration Schedule | 1 | 2010 | 374 | 0.080 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 59 | 0.080 |
Why?
| Societies, Medical | 1 | 2010 | 200 | 0.080 |
Why?
| Stress, Mechanical | 1 | 2009 | 92 | 0.080 |
Why?
| Acid Phosphatase | 1 | 2009 | 12 | 0.080 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2009 | 182 | 0.080 |
Why?
| Integrases | 3 | 2015 | 44 | 0.080 |
Why?
| Connexin 43 | 1 | 2008 | 25 | 0.080 |
Why?
| Education, Medical, Continuing | 1 | 2009 | 72 | 0.080 |
Why?
| Inflammation Mediators | 1 | 2009 | 115 | 0.080 |
Why?
| Receptors, Parathyroid Hormone | 1 | 2008 | 9 | 0.080 |
Why?
| Ovariectomy | 4 | 2013 | 113 | 0.070 |
Why?
| Multienzyme Complexes | 2 | 2010 | 40 | 0.070 |
Why?
| Isoenzymes | 1 | 2009 | 166 | 0.070 |
Why?
| Postmenopause | 1 | 2009 | 82 | 0.070 |
Why?
| Mitosis | 1 | 2008 | 88 | 0.070 |
Why?
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2008 | 25 | 0.070 |
Why?
| Practice Guidelines as Topic | 1 | 2011 | 488 | 0.070 |
Why?
| Linear Models | 1 | 2009 | 287 | 0.070 |
Why?
| Aged | 4 | 2013 | 10121 | 0.070 |
Why?
| Administration, Oral | 1 | 2009 | 451 | 0.070 |
Why?
| Intercellular Signaling Peptides and Proteins | 2 | 2010 | 105 | 0.070 |
Why?
| Mutagenesis, Site-Directed | 1 | 2007 | 95 | 0.070 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 582 | 0.070 |
Why?
| Gonadal Steroid Hormones | 1 | 2007 | 39 | 0.070 |
Why?
| X Chromosome | 1 | 2006 | 13 | 0.070 |
Why?
| Asthma | 1 | 2011 | 316 | 0.070 |
Why?
| Shc Signaling Adaptor Proteins | 3 | 2011 | 19 | 0.070 |
Why?
| Membrane Glycoproteins | 2 | 2005 | 244 | 0.070 |
Why?
| Quantitative Trait Loci | 1 | 2006 | 50 | 0.070 |
Why?
| Phosphorylation | 4 | 2010 | 528 | 0.070 |
Why?
| Osteoporosis, Postmenopausal | 1 | 2006 | 29 | 0.070 |
Why?
| Body Weight | 2 | 2010 | 523 | 0.060 |
Why?
| Carrier Proteins | 2 | 2005 | 313 | 0.060 |
Why?
| Weightlessness | 1 | 2006 | 13 | 0.060 |
Why?
| Rheumatology | 1 | 2006 | 6 | 0.060 |
Why?
| Lipoproteins, LDL | 2 | 2018 | 169 | 0.060 |
Why?
| Adipocytes | 2 | 2004 | 132 | 0.060 |
Why?
| Phenotype | 3 | 2015 | 789 | 0.060 |
Why?
| Absorptiometry, Photon | 3 | 2016 | 162 | 0.060 |
Why?
| Dose-Response Relationship, Drug | 1 | 2009 | 1378 | 0.060 |
Why?
| Diet, High-Fat | 2 | 2018 | 236 | 0.060 |
Why?
| Bone Diseases, Developmental | 1 | 2024 | 17 | 0.060 |
Why?
| Neuromuscular Junction | 1 | 2024 | 9 | 0.060 |
Why?
| Thiazolidinediones | 1 | 2004 | 83 | 0.060 |
Why?
| Compressive Strength | 1 | 2004 | 12 | 0.060 |
Why?
| Seminal Vesicles | 1 | 2004 | 13 | 0.050 |
Why?
| Tensile Strength | 1 | 2003 | 31 | 0.050 |
Why?
| Arachidonate 12-Lipoxygenase | 2 | 2016 | 13 | 0.050 |
Why?
| Arachidonate 15-Lipoxygenase | 2 | 2016 | 13 | 0.050 |
Why?
| Femur Neck | 1 | 2003 | 7 | 0.050 |
Why?
| Treatment Outcome | 2 | 2013 | 5422 | 0.050 |
Why?
| Mitochondrial Proteins | 1 | 2024 | 89 | 0.050 |
Why?
| Cysteine Endopeptidases | 1 | 2003 | 67 | 0.050 |
Why?
| Pregnancy, Animal | 1 | 2003 | 33 | 0.050 |
Why?
| Cell Division | 1 | 2004 | 291 | 0.050 |
Why?
| Diet, Reducing | 1 | 2003 | 36 | 0.050 |
Why?
| Mice, 129 Strain | 2 | 2013 | 37 | 0.050 |
Why?
| RNA, Messenger | 4 | 2010 | 1132 | 0.050 |
Why?
| Analysis of Variance | 2 | 2014 | 554 | 0.050 |
Why?
| Extracellular Matrix Proteins | 2 | 2014 | 69 | 0.050 |
Why?
| Sex Characteristics | 1 | 2003 | 198 | 0.050 |
Why?
| Neoplasm Proteins | 1 | 2003 | 334 | 0.040 |
Why?
| 5' Untranslated Regions | 1 | 2020 | 30 | 0.040 |
Why?
| Cell Cycle Proteins | 2 | 2013 | 169 | 0.040 |
Why?
| Models, Biological | 3 | 2010 | 735 | 0.040 |
Why?
| Macrophages | 2 | 2016 | 379 | 0.040 |
Why?
| Transcription, Genetic | 3 | 2010 | 378 | 0.040 |
Why?
| Gene Knock-In Techniques | 2 | 2010 | 22 | 0.040 |
Why?
| Cell Survival | 1 | 2002 | 612 | 0.040 |
Why?
| Bone Marrow | 2 | 2013 | 364 | 0.040 |
Why?
| Child | 2 | 2024 | 7248 | 0.040 |
Why?
| Proteins | 1 | 2003 | 348 | 0.040 |
Why?
| Muscle, Skeletal | 1 | 2024 | 804 | 0.040 |
Why?
| Young Adult | 2 | 2020 | 4329 | 0.030 |
Why?
| Antioxidants | 2 | 2010 | 256 | 0.030 |
Why?
| Oxidation-Reduction | 1 | 2018 | 326 | 0.030 |
Why?
| Mice, Inbred BALB C | 1 | 2017 | 312 | 0.030 |
Why?
| Models, Animal | 1 | 2017 | 234 | 0.030 |
Why?
| Immunomagnetic Separation | 1 | 2016 | 7 | 0.030 |
Why?
| Genotype | 2 | 2008 | 566 | 0.030 |
Why?
| Monocytes | 1 | 2016 | 130 | 0.030 |
Why?
| Interleukin-1beta | 1 | 2016 | 86 | 0.030 |
Why?
| Time Factors | 3 | 2008 | 2968 | 0.030 |
Why?
| Cell Lineage | 1 | 2015 | 85 | 0.030 |
Why?
| Immunoblotting | 1 | 2015 | 116 | 0.030 |
Why?
| Mutation | 1 | 2020 | 1347 | 0.030 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 2 | 2005 | 33 | 0.030 |
Why?
| Hyperthyroidism | 1 | 2014 | 28 | 0.030 |
Why?
| DNA Primers | 1 | 2014 | 208 | 0.030 |
Why?
| Fractures, Stress | 1 | 2013 | 5 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 185 | 0.030 |
Why?
| Gene Knockout Techniques | 1 | 2013 | 46 | 0.030 |
Why?
| Flow Cytometry | 1 | 2016 | 478 | 0.030 |
Why?
| Alveolar Ridge Augmentation | 1 | 2013 | 1 | 0.030 |
Why?
| Periodontium | 1 | 2013 | 2 | 0.030 |
Why?
| Esthetics, Dental | 1 | 2013 | 6 | 0.030 |
Why?
| Alveolar Process | 1 | 2013 | 7 | 0.030 |
Why?
| Adipogenesis | 1 | 2013 | 49 | 0.030 |
Why?
| Alveolar Bone Loss | 1 | 2013 | 9 | 0.030 |
Why?
| Atrophy | 1 | 2013 | 45 | 0.030 |
Why?
| Bone Transplantation | 1 | 2013 | 42 | 0.030 |
Why?
| Microtubule-Associated Proteins | 1 | 2013 | 65 | 0.030 |
Why?
| Mice, Mutant Strains | 1 | 2012 | 70 | 0.030 |
Why?
| Homeostasis | 1 | 2014 | 201 | 0.020 |
Why?
| Uterus | 1 | 2013 | 88 | 0.020 |
Why?
| Infant | 1 | 2020 | 3733 | 0.020 |
Why?
| Surgical Flaps | 1 | 2013 | 110 | 0.020 |
Why?
| Histological Techniques | 1 | 2011 | 9 | 0.020 |
Why?
| Adiposity | 1 | 2013 | 143 | 0.020 |
Why?
| MAP Kinase Kinase 4 | 1 | 2011 | 29 | 0.020 |
Why?
| Chondrocytes | 1 | 2011 | 41 | 0.020 |
Why?
| Inflammation | 1 | 2016 | 641 | 0.020 |
Why?
| Image Processing, Computer-Assisted | 1 | 2013 | 253 | 0.020 |
Why?
| beta Catenin | 1 | 2011 | 102 | 0.020 |
Why?
| Health Planning Guidelines | 1 | 2010 | 12 | 0.020 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 169 | 0.020 |
Why?
| Hip Fractures | 1 | 2010 | 47 | 0.020 |
Why?
| Solubility | 1 | 2010 | 79 | 0.020 |
Why?
| Genetic Markers | 1 | 2010 | 109 | 0.020 |
Why?
| Smad1 Protein | 1 | 2010 | 5 | 0.020 |
Why?
| Glutathione Reductase | 1 | 2010 | 14 | 0.020 |
Why?
| Bone Morphogenetic Proteins | 1 | 2010 | 58 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2011 | 461 | 0.020 |
Why?
| Chimera | 1 | 2010 | 10 | 0.020 |
Why?
| Glycoproteins | 1 | 2010 | 122 | 0.020 |
Why?
| Transgenes | 1 | 2010 | 51 | 0.020 |
Why?
| Bone Morphogenetic Protein 2 | 1 | 2010 | 45 | 0.020 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 82 | 0.020 |
Why?
| Gene Targeting | 1 | 2010 | 31 | 0.020 |
Why?
| Organ Specificity | 1 | 2010 | 115 | 0.020 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 202 | 0.020 |
Why?
| Enzyme Activation | 1 | 2010 | 270 | 0.020 |
Why?
| Bone Marrow Cells | 1 | 2010 | 190 | 0.020 |
Why?
| Diagnostic Imaging | 1 | 2010 | 181 | 0.020 |
Why?
| Thymidine Kinase | 1 | 2008 | 19 | 0.020 |
Why?
| Ganciclovir | 1 | 2008 | 24 | 0.020 |
Why?
| Osteocalcin | 1 | 2008 | 45 | 0.020 |
Why?
| Cohort Studies | 1 | 2013 | 1542 | 0.020 |
Why?
| Gene Silencing | 1 | 2008 | 118 | 0.020 |
Why?
| Up-Regulation | 1 | 2010 | 454 | 0.020 |
Why?
| Collagen Type I | 1 | 2008 | 83 | 0.020 |
Why?
| Lymphoid Tissue | 1 | 2007 | 20 | 0.020 |
Why?
| Phosphoproteins | 1 | 2008 | 119 | 0.020 |
Why?
| Hormones | 1 | 2007 | 59 | 0.020 |
Why?
| DNA Replication | 1 | 2008 | 160 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2013 | 2279 | 0.020 |
Why?
| Weight Gain | 1 | 2008 | 240 | 0.020 |
Why?
| Prospective Studies | 1 | 2013 | 2481 | 0.020 |
Why?
| Species Specificity | 1 | 2006 | 192 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2008 | 467 | 0.020 |
Why?
| Blotting, Northern | 1 | 2005 | 106 | 0.020 |
Why?
| Histocytochemistry | 1 | 2005 | 45 | 0.020 |
Why?
| Densitometry | 1 | 2004 | 13 | 0.010 |
Why?
| Mesoderm | 1 | 2004 | 27 | 0.010 |
Why?
| Ligands | 1 | 2004 | 206 | 0.010 |
Why?
| Sex Factors | 1 | 2006 | 727 | 0.010 |
Why?
| PPAR gamma | 1 | 2004 | 72 | 0.010 |
Why?
| Fatty Acids | 1 | 2004 | 149 | 0.010 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2006 | 505 | 0.010 |
Why?
| bcl-Associated Death Protein | 1 | 2003 | 9 | 0.010 |
Why?
| Dactinomycin | 1 | 2003 | 23 | 0.010 |
Why?
| Culture Media, Conditioned | 1 | 2003 | 47 | 0.010 |
Why?
| Core Binding Factor Alpha 1 Subunit | 1 | 2003 | 47 | 0.010 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 34 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2006 | 528 | 0.010 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 50 | 0.010 |
Why?
| Age Factors | 1 | 2006 | 1132 | 0.010 |
Why?
| Models, Genetic | 1 | 2003 | 169 | 0.010 |
Why?
| Rats, Long-Evans | 1 | 2003 | 25 | 0.010 |
Why?
| Iodine Radioisotopes | 1 | 2003 | 34 | 0.010 |
Why?
| HeLa Cells | 1 | 2003 | 265 | 0.010 |
Why?
| Adiponectin | 1 | 2003 | 46 | 0.010 |
Why?
| Gene Expression | 1 | 2005 | 618 | 0.010 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2003 | 117 | 0.010 |
Why?
| Hypoglycemic Agents | 1 | 2004 | 211 | 0.010 |
Why?
| Mice, Inbred Strains | 1 | 2003 | 163 | 0.010 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 129 | 0.010 |
Why?
| RNA | 1 | 2003 | 168 | 0.010 |
Why?
| Kinetics | 1 | 2003 | 626 | 0.010 |
Why?
| Adolescent | 1 | 2013 | 6739 | 0.010 |
Why?
| Rats | 1 | 2003 | 3220 | 0.010 |
Why?
| Pregnancy | 1 | 2003 | 2680 | 0.010 |
Why?
|
|
Weinstein's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|